![]()
|
|
||||||||
J. Biol. Chem., Vol. 281, Issue 40, 29886-29896, October 6, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




1
From the
Unit of Molecular Neurobiology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, 171 77 Stockholm, Sweden and
Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada
The RET receptor tyrosine kinase is important for several different biological functions during development. The recruitment at the phosphorylated Tyr1062 site in RET of a number of different phosphotyrosine binding (PTB) domain-containing adaptor proteins, including Shc and Frs2, plays a dominant role for the multiple different biological functions of the RET receptor during development, including stimulation of cell survival. Here, we demonstrate that a competitive recruitment of Shc as opposed to Frs2 mediates the survival signaling arising from RET activation. Based on results from a peptide array, we have genetically engineered the PTB domain binding site of RET to rewire its recruitment of the PTB proteins Shc and Frs2. An engineered RET that has a competitive interaction with Shc at the expense of Frs2, but not a RET receptor that only recruits Frs2, activates cell survival signaling pathways and is protective from cell death in neuronal SK-N-MC cells. Thus, cell type-specific functions involve a competitive recruitment of different PTB adaptor molecules by RET that activate selective signaling pathways.
Received for publication, January 17, 2006 , and in revised form, June 21, 2006.
* This work was supported by the Swedish Cancer Society, the Swedish Medical Research Council, the Swedish Foundation for Strategic Research (Center of Excellence in Developmental Biology (CEDB) grant) (to P. E.), and the Karolinska Institute M.D.-Ph.D. program (to T. K. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed: Unit of Molecular Neurobiology, Dept. of Medical Biochemistry and Biophysics, Karolinska Institute, 171 77 Stockholm, Sweden. Tel.: 468-52487659; Fax: 468-341960; E-mail: Patrik.Ernfors{at}ki.se.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
V. Bryja, D. Gradl, A. Schambony, E. Arenas, and G. Schulte beta-Arrestin is a necessary component of Wnt/beta-catenin signaling in vitro and in vivo PNAS, April 17, 2007; 104(16): 6690 - 6695. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Smith, W. R. Hardy, J. M. Murphy, N. Jones, and T. Pawson Screening for PTB Domain Binding Partners and Ligand Specificity Using Proteome-Derived NPXY Peptide Arrays Mol. Cell. Biol., November 15, 2006; 26(22): 8461 - 8474. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |